Millennium Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$430K 6751
2023
Q4
$430K Buy
+20,000
New +$357K ﹤0.01% 4733
2022
Q1
Sell
-40,000
Closed -$3.24M 7618
2021
Q4
$3.24M Buy
+40,000
New +$4.01M ﹤0.01% 3311
2021
Q3
Sell
-20,000
Closed -$3.32M 7350
2021
Q2
$3.32M Buy
+20,000
New +$3.12M ﹤0.01% 3320
2020
Q1
Sell
-21,000
Closed -$2.47M 4621
2019
Q4
$2.47M Buy
+21,000
New +$2.08M ﹤0.01% 2474
2019
Q1
Sell
-130,900
Closed -$5.09M 4399
2018
Q4
$5.09M Sell
130,900
-59,100
-31% -$2.63M 0.01% 1578
2018
Q3
$10.8M Buy
+190,000
New +$11.9M 0.01% 1258
2017
Q1
Sell
-90,000
Closed -$6.54M 3911
2016
Q4
$6.54M Buy
90,000
+50,000
+125% +$4.28M 0.01% 1154
2016
Q3
$4.18M Buy
40,000
+20,000
+100% +$1.81M 0.01% 1450
2016
Q2
$1.48M Buy
+20,000
New +$1.36M ﹤0.01% 1951

Other funds holding NVRO

Millennium Management's NVRO Position: Q2 2025 in Review

Millennium Management sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 331,014 shares — an estimated $1.93M sold.

Millennium Management first reported a position in NVRO in Q4 2014 and held it in 38 quarters. The position peaked at $72.7M in Q3 2017. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Millennium Management reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Millennium Management sold 331,014 NEVRO CORP. shares in Q2 2025, an estimated $1.93M.
  • Millennium Management first reported a position in NEVRO CORP. in Q4 2014 and held it in 38 quarters.
  • Millennium Management's NEVRO CORP. position peaked at $72.7M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.